TMDX - TransMedics Group - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TMDX is currently covered by 11 analysts with an average price target of $140.13. This is a potential upside of $18.02 (14.76%) from yesterday's end of day stock price of $122.11.

TransMedics Group's activity chart (see below) currently has 94 price targets and 104 ratings on display. The stock rating distribution of TMDX is 82.35% BUY and 17.65% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.25% with an average time for these price targets to be met of 160.5 days.

Highest price target for TMDX is $153, Lowest price target is $75, average price target is $110.75.

Most recent stock forecast was given by SURAJ KALIA from OPPENHEIMER on 08-May-2025. First documented stock forecast 27-May-2019.

Currently out of the existing stock ratings of TMDX, 42 are a BUY (82.35%), 9 are a HOLD (17.65%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$130

$18.5 (16.59%)

$125

5 days ago
(08-May-2025)

9/13 (69.23%)

$18.5 (16.59%)

171

Buy

$125

$13.5 (12.11%)

$105

5 days ago
(08-May-2025)

7/11 (63.64%)

$13.5 (12.11%)

69

Hold

21 days ago
(22-Apr-2025)

2/3 (66.67%)

$32.96 (43.35%)

180

Buy

$104

$-7.5 (-6.73%)

$104

2 months 3 days ago
(10-Mar-2025)

13/13 (100%)

$36.35 (53.73%)

260

Hold

$75

$-36.5 (-32.74%)

$116

4 months 27 days ago
(16-Dec-2024)

7/9 (77.78%)

$9.29 (14.14%)

19

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TMDX (TransMedics Group) average time for price targets to be met?

On average it took 160.5 days on average for the stock forecasts to be realized with a an average price target met ratio 83.25

Which analyst has the current highest performing score on TMDX (TransMedics Group) with a proven track record?

MIKE MATSON

Which analyst has the most public recommendations on TMDX (TransMedics Group)?

Mike Matson works at NEEDHAM and has 36 price targets and 39 ratings on TMDX

Which analyst is the currently most bullish on TMDX (TransMedics Group)?

Cecilia Furlong with highest potential upside - $41.5

Which analyst is the currently most reserved on TMDX (TransMedics Group)?

David Lewis with lowest potential downside - -$96.5

TransMedics Group in the News

Why TransMedics Stock Is Skyrocketing Today

Key Points TransMedics delivered revenue and net income growth of 48% and 111% in its first-quarter earnings. The company continues to see streamlining efficiencies from its nascent logistical network. Solidly profitable and with a promising growth story, TransMedics remains one of my favorite investments. 10 stocks we like better than TransMedics Group › Shares of...

Former Highflier TransMedics Catapults To Seven-Month High On Liver-Driven Beat

TransMedics stock rocketed Friday after the company beat Wall Street’s first-quarter expectations and hiked its 2025 revenue guidance. Continue Reading View Comments
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?